Rkl Wealth Management LLC Eli Lilly & CO Transaction History

Rkl Wealth Management LLC

$1.1 Billion
Q3 2024

A detailed history of Rkl Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rkl Wealth Management LLC holds 2,818 shares of LLY stock, worth $2.24 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

2,818

Previous 2,904 2.96%

Holding current value

$2.24 Million

Previous $2.63 Million 5.06%

% of portfolio

0.23%

Previous 0.25%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$772.14 - $960.02 $66,404 - $82,561	-86 Reduced 2.96%	2,818 $2.5 Million
Q2 2024 Jul 17, 2024	SELL	$724.87 - $909.04 $213,111 - $267,257	-294 Reduced 9.19%	2,904 $2.63 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $114,886 - $153,702	194 Added 6.46%	3,198 $2.49 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $1.03 Million - $1.22 Million	1,964 Added 188.85%	3,004 $1.75 Million
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $40,427 - $55,734	93 Added 9.82%	1,040 $558,000
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $10,872 - $14,538	-31 Reduced 3.17%	947 $444,000
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $10,872 - $12,768	-35 Reduced 3.46%	978 $335,000
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $6,752 - $7,868	-21 Reduced 2.03%	1,013 $370,000
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $3,557 - $4,054	12 Added 1.17%	1,034 $334,000
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $11,985 - $14,072	-43 Reduced 4.04%	1,022 $331,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $60,550 - $75,248	258 Added 31.97%	1,065 $305,000
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $181,453 - $225,185	807 New	807 $223,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $591,450 - $727,862	-2,669 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $481,887 - $623,318	2,669 New	2,669 $613,000
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $207,536 - $268,665	-1,263 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $164,770 - $218,031	1,263 New	1,263 $213,000
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $225,744 - $242,136	-2,755 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $212,327 - $235,662	2,755	2,755 $237,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rkl Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rkl Wealth Management LLC with notifications on news.

Account

Rkl Wealth Management LLC Eli Lilly & CO Transaction History